Guided Exercise and Medication for Obesity in Kidney Disease
Sit Less, Interact and Move More (SLIMM) 2 Study
Recruiting
Phase 2
Interventional Study
Chronic Kidney Diseases
Obesity
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 20 and older
- Sex
- Any
- Trial phase
- Phase 2
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 156 (estimated)
- Sponsor
- Srinvasan Beddhu · Other
Who this trial is looking for
This trial is looking for people with chronic kidney disease and obesity. Participants will undergo guided exercise and may take a medication to help reduce sitting time and improve health.
Are You a Good Fit for This Trial?
You may be able to join if
- I have chronic kidney disease with an eGFR between 20 and 60.
- I can perform resistance training.
- I have access to a smartphone or compatible device.
You may not be able to join if
- I have type 1 diabetes.
- I have a history of gastroparesis.
- I sit for 25 minutes or less each hour on average.
- I have a history of pancreatitis.
- I have had bariatric surgery.
- I have a serious medical condition that could limit my life to less than 1 year.
- I am currently using oxygen during the day.
- I live with someone already in this study.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
* Prolonged sitting (sedentary behavior) is a risk factor for decreased kidney function, obesity, diabetes and mortality. Prolonged sitting is associated with decreased kidney function and increased risk of diabetes, heart disease and death.
* In a previous pilot study funded by NIH, it was shown that a Sit Less, Interact and Move More (SLIMM) intervention targeting sedentary behavior in people wi…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) Glomerular Filtration Rate (eGFR) 20 to \<60 mL/min/1.73m\^2
* Able to perform resistance training
* Access to compatible "smartphone" or device (i.e., Android, Kindle or Apple with internet connectivity or mobile net…
Contacts